Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 1/2019

07.06.2019 | Research article

Impact of alexithymia on glycemic control among Lebanese adults with type 2 diabetes

verfasst von: Chirine Fares, Robert Bader, José-Noel Ibrahim

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Alexithymia, defined as the inability of a person to identify, describe and express emotions, has been found to influence glycemic control in type 2 diabetes patients (D2). The characteristics and influencing factors of alexithymia and the association of this psychological construct with D2 has not yet been studied in Lebanon where 14.6% of adults are diagnosed with the disease. This study aims at evaluating the prevalence of alexithymia and its relationship with glycemic control among Lebanese adults with D2.

Methods

Alexithymia was assessed in 104 patients diagnosed with D2 and 100 healthy controls using the 20-item Toronto Alexithymia Scale (TAS-20). The impact of alexithymia on glycemic control was evaluated using HbA1c values, fasting blood glucose levels, number of severe hyperglycemic episodes and hospitalizations for hyperglycemia within the past months.

Results

Alexithymia prevalence was significantly higher in D2 patients compared to controls (35.5% vs 15%). Patients with alexithymia showed higher levels of HbA1c and glucose in comparison to those without alexithymia. Consistently, significant positive correlations were found between the TAS-20 total and subscale scores and both HbA1c and glucose levels. Alexithymic patients had three times more severe hyperglycemic episodes and five times more hospitalizations for hyperglycemia compared to those without alexithymia. According to multivariate regression analysis, lifestyle factors alone were not found predictive of alexithymia in D2 patients.

Conclusion

Given the impact of alexithymia on D2 regulation, screening of alexithymia in case of D2 and appropriate psychological follow-up are important for a better prognosis, management and treatment of the disease.
Literatur
4.
Zurück zum Zitat Chen L, Pei J-H, Kuang J, Chen H-M, Chen Z, Li Z-W, et al. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism. 2015;64:338–47.CrossRefPubMed Chen L, Pei J-H, Kuang J, Chen H-M, Chen Z, Li Z-W, et al. Effect of lifestyle intervention in patients with type 2 diabetes: a meta-analysis. Metabolism. 2015;64:338–47.CrossRefPubMed
5.
Zurück zum Zitat Whitworth SR, Bruce DG, Starkstein SE, Davis WA, Davis TME, Bucks RS. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: the Fremantle diabetes study phase II. Diabetes Res Clin Pract. 2016;122:190–7.CrossRefPubMed Whitworth SR, Bruce DG, Starkstein SE, Davis WA, Davis TME, Bucks RS. Lifetime depression and anxiety increase prevalent psychological symptoms and worsen glycemic control in type 2 diabetes: the Fremantle diabetes study phase II. Diabetes Res Clin Pract. 2016;122:190–7.CrossRefPubMed
6.
Zurück zum Zitat Luca A, Luca M, Di Mauro M, Palermo F, Rampulla F, Calandra C. Alexithymia, more than depression, influences glycaemic control of type 2 diabetic patients. J Endocrinol Investig. 2015;38:653–60.CrossRef Luca A, Luca M, Di Mauro M, Palermo F, Rampulla F, Calandra C. Alexithymia, more than depression, influences glycaemic control of type 2 diabetic patients. J Endocrinol Investig. 2015;38:653–60.CrossRef
7.
Zurück zum Zitat Topsever P, Filiz TM, Salman S, Sengul A, Sarac E, Topalli R, et al. Alexithymia in diabetes mellitus. Scott Med J. 2006;51:15–20.CrossRefPubMed Topsever P, Filiz TM, Salman S, Sengul A, Sarac E, Topalli R, et al. Alexithymia in diabetes mellitus. Scott Med J. 2006;51:15–20.CrossRefPubMed
8.
Zurück zum Zitat Bastin P, Luminet O, Buysschaert M, Luts A. Contrôle du diabète et alexithymie : le rôle de l’identification et de la verbalisation des émotions. Louvain Méd. 2004;123:252. Bastin P, Luminet O, Buysschaert M, Luts A. Contrôle du diabète et alexithymie : le rôle de l’identification et de la verbalisation des émotions. Louvain Méd. 2004;123:252.
9.
Zurück zum Zitat Ahmadieh H, Itani H, Itani S, Sidani K, Kassem M, Farhat K, et al. Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study. Diabetes Metab Syndr Obes Targets Ther. 2018;11:717–28.CrossRef Ahmadieh H, Itani H, Itani S, Sidani K, Kassem M, Farhat K, et al. Diabetes and depression in Lebanon and association with glycemic control: a cross-sectional study. Diabetes Metab Syndr Obes Targets Ther. 2018;11:717–28.CrossRef
10.
Zurück zum Zitat Care CTF on PH. Recommendations on screening for type 2 diabetes in adults. CMAJ. 2012;184:1687–96.CrossRef Care CTF on PH. Recommendations on screening for type 2 diabetes in adults. CMAJ. 2012;184:1687–96.CrossRef
11.
Zurück zum Zitat Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto alexithymia scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23–32.CrossRefPubMed Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto alexithymia scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23–32.CrossRefPubMed
12.
Zurück zum Zitat Parker JDA, Taylor GJ, Bagby RM. The 20-item Toronto alexithymia scale. III. Reliability and factorial validity in a community population. J Psychosom Res. 2003;55:269–75.CrossRefPubMed Parker JDA, Taylor GJ, Bagby RM. The 20-item Toronto alexithymia scale. III. Reliability and factorial validity in a community population. J Psychosom Res. 2003;55:269–75.CrossRefPubMed
13.
Zurück zum Zitat Loas G, Parker JDA, Otmani O, Verrier A, Fremaux D. Confirmatory factor analysis of the French translation of the 20-item Toronto alexithymia scale. Percept Mot Skills. 1997;85:1018.CrossRefPubMed Loas G, Parker JDA, Otmani O, Verrier A, Fremaux D. Confirmatory factor analysis of the French translation of the 20-item Toronto alexithymia scale. Percept Mot Skills. 1997;85:1018.CrossRefPubMed
14.
Zurück zum Zitat Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;20:586–90.PubMed Bondar RJ, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem. 1974;20:586–90.PubMed
15.
Zurück zum Zitat American Diabetes Association. Standards of medical Care in Diabetes—2015 abridged for primary care providers. Clin Diabetes Publ Am Diabetes Assoc. 2015;33:97–111. American Diabetes Association. Standards of medical Care in Diabetes—2015 abridged for primary care providers. Clin Diabetes Publ Am Diabetes Assoc. 2015;33:97–111.
16.
Zurück zum Zitat Avci D, Kelleci M. Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control. Patient Prefer Adherence. 2016;10:1271–7.CrossRefPubMedPubMedCentral Avci D, Kelleci M. Alexithymia in patients with type 2 diabetes mellitus: the role of anxiety, depression, and glycemic control. Patient Prefer Adherence. 2016;10:1271–7.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Damak R, Mnif L, Masmoudi J, Halwani N, Mnif F, Baati I, et al. P02-299 - alexithymia in diabetes type2. Eur Psychiatry. 2010;25:1008.CrossRef Damak R, Mnif L, Masmoudi J, Halwani N, Mnif F, Baati I, et al. P02-299 - alexithymia in diabetes type2. Eur Psychiatry. 2010;25:1008.CrossRef
18.
Zurück zum Zitat Mnif L, Damak R, Mnif F, Ouanes S, Abid M, Jaoua A, et al. Alexithymia impact on type 1 and type 2 diabetes: a case-control study. Ann Endocrinol. 2014;75:2013–9.CrossRef Mnif L, Damak R, Mnif F, Ouanes S, Abid M, Jaoua A, et al. Alexithymia impact on type 1 and type 2 diabetes: a case-control study. Ann Endocrinol. 2014;75:2013–9.CrossRef
20.
Zurück zum Zitat Salminen JK, Saarijärvi S, Aärelä E, Toikka T, Kauhanen J. Prevalence of alexithymia and its association with sociodemographic variables in the general population of Finland. J Psychosom Res. 1999;46:75–82.CrossRefPubMed Salminen JK, Saarijärvi S, Aärelä E, Toikka T, Kauhanen J. Prevalence of alexithymia and its association with sociodemographic variables in the general population of Finland. J Psychosom Res. 1999;46:75–82.CrossRefPubMed
21.
Zurück zum Zitat Stingl M, Naundorf K, vom Felde L, Bernd H. Alexithymia in type I and type II diabetes. Interv Obes Diabetes. 2018;1:1–4. Stingl M, Naundorf K, vom Felde L, Bernd H. Alexithymia in type I and type II diabetes. Interv Obes Diabetes. 2018;1:1–4.
22.
Zurück zum Zitat Levant RF, Hall RJ, Williams CM, Hasan NT. Gender differences in alexithymia. Psychol Men Masculinity. 2009;10:190–203.CrossRef Levant RF, Hall RJ, Williams CM, Hasan NT. Gender differences in alexithymia. Psychol Men Masculinity. 2009;10:190–203.CrossRef
23.
Zurück zum Zitat Abramson L, McClelland DC, Brown D, Kelner S. Alexithymic characteristics and metabolic control in diabetic and healthy adults. J Nerv Ment Dis. 1991;179:490–4.CrossRefPubMed Abramson L, McClelland DC, Brown D, Kelner S. Alexithymic characteristics and metabolic control in diabetic and healthy adults. J Nerv Ment Dis. 1991;179:490–4.CrossRefPubMed
24.
Zurück zum Zitat Contreras CM, Gutiérrez-García AG. Cognitive impairment in diabetes and poor glucose utilization in the intracellular neural milieu. Med Hypotheses. 2017;104:160–5.CrossRefPubMed Contreras CM, Gutiérrez-García AG. Cognitive impairment in diabetes and poor glucose utilization in the intracellular neural milieu. Med Hypotheses. 2017;104:160–5.CrossRefPubMed
26.
Zurück zum Zitat Morie KP, Yip SW, Nich C, Hunkele K, Carroll KM, Potenza MN. Alexithymia and addiction: a review and preliminary data suggesting neurobiological links to reward/loss processing. Curr Addict Rep. 2016;3:239–48.CrossRefPubMedPubMedCentral Morie KP, Yip SW, Nich C, Hunkele K, Carroll KM, Potenza MN. Alexithymia and addiction: a review and preliminary data suggesting neurobiological links to reward/loss processing. Curr Addict Rep. 2016;3:239–48.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Misterska E, Glowacki M, Adamczyk K, Glowacki J, Harasymczuk J. A longitudinal study of alexithymia in relation to physical activity in adolescent females with scoliosis subjected to cheneau brace treatment: preliminary report. Spine. 2014;39:E1026–34.CrossRefPubMed Misterska E, Glowacki M, Adamczyk K, Glowacki J, Harasymczuk J. A longitudinal study of alexithymia in relation to physical activity in adolescent females with scoliosis subjected to cheneau brace treatment: preliminary report. Spine. 2014;39:E1026–34.CrossRefPubMed
Metadaten
Titel
Impact of alexithymia on glycemic control among Lebanese adults with type 2 diabetes
verfasst von
Chirine Fares
Robert Bader
José-Noel Ibrahim
Publikationsdatum
07.06.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2019
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-019-00412-3

Weitere Artikel der Ausgabe 1/2019

Journal of Diabetes & Metabolic Disorders 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.